1例晚期肺癌癌痛伴支气管哮喘及肺部感染患者镇痛的药学实践

中国药物警戒 ›› 2019, Vol. 16 ›› Issue (8): 492-495.

• 安全性评价与合理用药 • 上一篇下一篇

1例晚期肺癌癌痛伴支气管哮喘及肺部感染患者镇痛的药学实践

蔡江霞¹, 安琳娜^2,*

1 新疆巴音郭楞蒙古自治州人民医院药学部,新疆库尔勒 841000;
2 新疆医科大学第一附属医院药学部,新疆乌鲁木齐 830001

收稿日期:2019-09-09 修回日期:2019-09-09 出版日期:2019-08-20 发布日期:2019-09-09
通讯作者: *安琳娜,女,主管药师,硕士,临床药学。E-mail：anlinna@126
作者简介:蔡江霞,女,主管药师,硕士,临床药学。

Pharmacological Practice for One Case of Advanced Lung Cancer with Bronchial Asthma and Pulmonary Infection

CAI Jiangxia¹, AN Linna^2,*

1 Department of Pharmacy, the People's Hospital of Xinjiang Bayingol Mongolian Autonomous Prefecture, Xinjiang Korla 841000;
2 Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Xinjiang Urumqi 830001

Received:2019-09-09 Revised:2019-09-09 Online:2019-08-20 Published:2019-09-09

摘要/Abstract

摘要： 目的探讨临床药师在晚期肺癌癌痛伴支气管哮喘患者治疗中的作用。方法临床药师基于1例晚期肺癌重度癌痛伴支气管哮喘病例,结合其疾病特点,对患者镇痛药物方案及评价、不良反应防范、抗感染药物选择等实施药学监护。结果临床药师提出了个体化治疗方案,医师采纳建议,保障了患者用药安全,提高了患者生活质量和临床药物治疗水平。结论临床药师与医师协作,利于优化患者个体化治疗方案,从药物选择、用药禁忌、不良反应防范等方面保障患者用药安全有效。

关键词: 肺癌, 癌痛, 哮喘, 临床药师, 药学监护

Abstract: Objective To explore the role of clinical pharmacists in the treatment of patients with advanced lung cancer and bronchial asthma. Methods Based on one case of advanced lung cancer with severe pain and bronchial asthma, the clinical pharmacists carried out pharmaceutical care from analgesic drugs selection and evaluation, adverse reactions precaution and anti-infection drugs choice etc. Results The clinical pharmacist proposed individualized treatment, and the doctor adopted the recommendation to ensure the patient's safe use of medication, and improved the quality of life and the level of clinical drug treatment. Conclusion The collaboration of clinical pharmacists and clinicians is benefit to optimize patients' individualized treatment regimens and ensure the safety and effect of drugs from drug selection, contraindication, adverse reaction prevention etc.

Key words: lung cancer, cancer pain, asthma, clinical pharmacists, pharmaceutical care

中图分类号:

蔡江霞, 安琳娜. 1例晚期肺癌癌痛伴支气管哮喘及肺部感染患者镇痛的药学实践[J]. 中国药物警戒, 2019, 16(8): 492-495.

CAI Jiangxia, AN Linna. Pharmacological Practice for One Case of Advanced Lung Cancer with Bronchial Asthma and Pulmonary Infection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(8): 492-495.

参考文献

[1] 陈万青, 张思维, 曾红梅, 等. 中国2010年恶性肿瘤发病率和死亡[J]. 中国肿瘤, 2014, 23(1): 1-10.
[2] 徐丽. 癌痛管理中规范化临床药学服务模式的建立及应用[J]. 临床合理用药杂志, 2019, 12(8): 96-97.
[3] 纪京绪, 杜彩云. 阶梯性镇痛护理对恶性肿瘤患者负性情绪、疼痛状况的影响[J]. 实用临床医药杂志, 2019, 23(4): 129-132.
[4] 贾继媛. 规范化癌痛护理对癌痛患者心理状态、疼痛程度及服药依从性的影响[J]. 中国民康医学, 2019, 31(3): 170-172.
[5] 俞丽华, 刘孟娟, 王增. 阿片类癌痛治疗药物制剂的研究进展[J]. 中国药物警戒, 2014, 11(1): 19-22.
[6] National Comprehensive Cancer Network( NCCN). NCCN clinical practice guidelines in Oncology: Adult Cancer Pain (Version 2. 2019) [EB/OL]. (2019-03-15)[2019-06-11]. http://guide.medlive.cn/guideline/17684.
[7] 吕小东. 支气管哮喘防治指南(2016年版)[J]. 中华结核和呼吸杂志, 2016, 39(9):675-697.
[8] Temel J S, Pirl W F, Lynch T J.Comprehensive symptom management in patients with advanced-stage non-small-cell lung cancer[J]. Clin Lung Cancer, 2006, 7(4):241-249.
[9] Yamaguchi T, Goya S, Kohara H, et al.Treatment Recommendations for Respiratory Symptoms in Cancer Patients: Clinical Guidelines from the Japanese Society for Palliative Medicine[J]. J Palliat Med, 2016, 19(9):925-935.
[10] Kloke M, Cherny N.Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines[J]. Annals of Oncology, 2015, 26(suppl 5):v169-v173.
[11] 呼吸困难诊断、评估与处理的专家共识组. 呼吸困难诊断、评估与处理的专家共识[J]. 中华内科杂志, 2014, 53(4):337-341.
[12] Parshall M B, Schwartzstein R M, Adams L, et al.An Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of Dyspnea[J]. Am J Respir Crit Care Med, 2011, 185(4):435-452.
[13] Temel J S, Pirl W F, Lynch T J.Comprehensive symptom management in patients with advanced-stage non-small-cell lung cancer[J]. Clin Lung Cancer, 2006, 7(4):241-249.
[14] Currow D C, McDonald C, Oaten S, et al. Once-daily opioids for chronic dyspnea: a dose increment and pharmac-ovigilance study[J]. J Pain Symptom Manage, 2011, 42(3): 388-399.
[15] Johnson H, Paulozzi L, Porucznik C, et al.Decline in drug overdose deaths after state policy changes-Florida, 2010-2012[J]. Mmwr Morbid Mortal Weekly Report, 2014, 63(26):569.
[16] Zacny J P, Paice J A, Coalson D W.Separate and combined psychopharmacological effects of alprazolam and oxycodone in healthy volunteers[J]. Drug Alcohol Depen, 2012, 124(3):274-282.
[17] Jann M, Kennedy W K, Lopez G.Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics[J]. J Pharm Pract, 2014, 27(1):5-16.
[18] Dublin S, Walker R L, Jackson M L, et al.Use of Opioids or Benzodiazepines and Risk of Pneumonia in Older Adults: A Population-Based Case-Control Study[J]. J Am Geriatr Soc, 2011, 59(10): 1899-1907.

1例晚期肺癌癌痛伴支气管哮喘及肺部感染患者镇痛的药学实践

Pharmacological Practice for One Case of Advanced Lung Cancer with Bronchial Asthma and Pulmonary Infection

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	范凯凯, 王聪, 刘洪峰, 王西勇. 临床药师对某院丙氨酰谷氨酰胺注射液应用干预分析[J]. 中国药物警戒, 2024, 21(2): 181-184.
[2]	李娜, 郭军, 郭文佳, 吕茵茵, 李彩宏, 牟向东. 奥马珠单抗注射剂治疗哮喘致迟发型皮肤过敏反应1 例分析[J]. 中国药物警戒, 2024, 21(2): 211-212.
[3]	张夏兰, 袁静, 吴斌, 秦媛媛. 甲磺酸阿帕替尼在恶性肿瘤患者的用药特征分析[J]. 中国药物警戒, 2023, 20(8): 927-932.
[4]	王然, 李轶凡, 刘小艳, 冯欣. 1例妊娠期药物暴露风险的药学监护[J]. 中国药物警戒, 2023, 20(8): 933-934.
[5]	陈婕, 秦侃. 肠外营养个体化给药实践评价[J]. 中国药物警戒, 2023, 20(7): 812-816.
[6]	刘婧, 夏亮, 张世杰. 1例多元药物过敏急性胰腺炎患者行药物激发试验的药学监护[J]. 中国药物警戒, 2023, 20(7): 822-824.
[7]	杨岩, 周德喜, 吴欣俐, 薛淑雅, 丁海华, 张泉, 张云玲. 84例新型抗肿瘤药品不良反应报告分析[J]. 中国药物警戒, 2023, 20(3): 334-338.
[8]	刘亚迪, 王雪, 殷晓阳, 刘泽宇, 张晓朦, 张冰, 林志健. 基于CiteSpace和生物信息学技术评估葛根素在肿瘤辅助治疗中的临床应用与安全风险[J]. 中国药物警戒, 2023, 20(12): 1407-1414.
[9]	林琦琪, 李馨阳, 孟繁浩. 非小细胞肺癌培美曲塞的耐药机制研究[J]. 中国药物警戒, 2023, 20(11): 1201-1208.
[10]	姚鑫, 葛秋格, 李亚敏, 王一帆, 李媛媛, 刘志强. 2018~2022年某院新型抗肿瘤药物消化系统不良反应分析[J]. 中国药物警戒, 2023, 20(11): 1273-1278.
[11]	郑金凤, 王景红. 1例多药联用致室性心律失常的药学监护[J]. 中国药物警戒, 2023, 20(11): 1279-1281.
[12]	苏甦, 伍诗琪, 张青霞, 闫素英. 1例吲达帕胺致粒细胞缺乏症患者的药学监护[J]. 中国药物警戒, 2023, 20(11): 1282-1285.
[13]	梁艳, 闫加庆, 杨珺. 注射用培美曲塞二钠致双侧小腿罕见硬皮样皮肤1例分析[J]. 中国药物警戒, 2023, 20(11): 1293-1295.
[14]	陈刚, 李岩, 姜彩虹, 解沛涛, 苏长海. 索凡替尼片和羟考酮缓释片致深度昏迷和重度药源性肝损伤1例分析[J]. 中国药物警戒, 2023, 20(11): 1296-1298.
[15]	贾贝, 王伟华, 杨靓, 戴媛媛. 136例小分子激酶抑制剂不良反应分析[J]. 中国药物警戒, 2023, 20(10): 1163-1167.